What is the current price of a box of Anamorelin on the market?

Anamorelin is an oral gastropin receptor agonist, mainly used for the adjuvant treatment of cancer cachexia (such as lung cancer-related weight loss). As of 2025, the drug has not yet been approved for marketing in mainland China, and patients cannot obtain it through formal prescription channels in domestic hospitals. If it is needed for clinical use, patients need to use overseas medical channels or cross-border pharmaceutical services to purchase it.

The original version of the drug currently on the market is produced by Ono Pharmaceutical Company of Japan and has been officially approved for marketing in Japan. The efficacy and safety of this original version have been fully verified, so it is widely used in clinical use. According to market quotations, the price of a box of Anamorelin original medicine is about more than 3,000 yuan, which is relatively high. However, due to its stable quality and reliable source, it is still the first choice for some patients.

In addition to the original drug, Laos Lucius Pharmaceuticals has also launched a generic version of Anamorelin. This version has the same ingredients as the original drug and has similar clinical effects. The current price of generic drugs is about more than 2,000 yuan per box, which has a certain price advantage compared to Japanese original drugs. This is a more practical alternative for patients under greater financial pressure. However, when purchasing generic drugs, you should still ensure that they are obtained through formal channels to ensure drug quality and efficacy.
Considering that anamorelin has not yet been approved in China, patients should pay special attention to the source of the drug and the guidance of a doctor when purchasing and using it. Regardless of whether you choose original drugs or generic drugs, you should use them regularly after your doctor evaluates the indications and health status, and avoid taking medications by yourself. It is recommended to purchase drugs through formal overseas medical platforms or cross-border pharmaceutical service agencies to ensure drug safety and follow-up treatment. At the same time, body weight, muscle mass, and gastrointestinal function are regularly monitored to evaluate the efficacy of the drug and adjust the treatment plan.
Reference: https://www.drugs.com/